GSTM1 and colorectal carcinoma: A nationwide randomised controlled trial (RCT) is currently being carried out within the Dutch CRC screening programme to assess feasibility, acceptability and (cost-) effectiveness of such personalised screening intervals based on f-Hb concentration in those with a prior negative FIT (Breekveldt et al., 2023b).